Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, applauds the progressive expansion of coverage for continuous glucose monitoring systems through the Non-Insured Health Benefits (NIHB) program. Following an announcement made earlier…
Deenova, leader in Europa nelle soluzioni di automazione per le farmacie ospedaliere con terapie in dose unitaria, ha annunciato oggi l’aggiudicazione di due gare competitive UniHA in Francia per tre dei suoi robot leader di mercato ACCED, all’ospedale Drôme Vivarais a Montéléger e all’ospedale…
Deenova, la compañía líder en Europa en el suministro de soluciones automatizadas para la producción de dosis unitarias en la farmacia hospitalaria anunció hoy la adjudicación de dos licitaciones competitivas UniHA (cooperativa de compradores de hospitales públicos franceses) para tres de sus…
IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended March 31, 2023. “The markets served by our Health & Science Technologies businesses have strong fundamental secular growth trends. We remain well-positioned, solving difficult problems…
IDEX Corporation (NYSE:IEX) today announced it has entered into a definitive agreement to acquire Iridian Spectral Technologies (“Iridian”) for cash consideration of 150 million Canadian dollars (“CAD”), subject to customary adjustments. The acquisition complements existing IDEX optical coating expertise, allowing IDEX…
Today, leading all-in-one marketing solution for dental and medspa practices, Lasso MD, announced a $2M lead investment from Trestle Partners (“Trestle”), a New York-based private investment firm with significant expertise partnering with SaaS and Martech companies. “If we can simplify the…
A privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that results of the Investigation of Novel Surgical Imaging for Tumor Excision (INSITE) pivotal trial have been published online in NEJM Evidence and will be presented at…
Generate:Biomedicines and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to jointly discover and co-develop protein therapeutics for up to five oncology targets in advanced cancers, including small-cell and non-small-cell lung cancer. Under the co-development…
Azuba Corporation, www.azuba.com, announced the launch of their HIPAA-compliant Azuba Healthcare Platform with broad interoperability automation for all the 350,000+ health apps in the healthcare space at the annual HIMSS23 conference. This broad interoperability solution empowers patients and their caregivers to…
The market leader in providing AI-powered and SaaS-based capacity management, staffing, and patient flow software for health systems, today announced it has been named the highest, fully-rated company in the first-ever capacity optimization report by KLAS Research. Across LeanTaaS’ large customer…
Masimo (NASDAQ: MASI), a global leader in pulse oximetry and other innovative noninvasive monitoring technologies, today announced the launch of Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into their baby’s health data, helping them learn…
-Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFA™) technology and proprietary CellFX System® for the treatment of atrial fibrillation, today announced that it has entered into a stock purchase agreement with…